ELI LILLY & Co (LLY): SEC Filings & AI Analysis

Health Care. Latest 10-K, 10-Q, and 8-K filings for ELI LILLY & Co (LLY) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.

Most recent filing — 8-K filed August 5, 2026: BULLISH Concern level: MODERATE.

Company overview — key questions

Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.

What is ELI LILLY & Co (LLY)?

ELI LILLY & Co is a publicly traded company in the Health Care space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.

What are LLY's most recent SEC filings?

Recent filings: 8-K (August 5, 2026), 10-Q (August 5, 2026), 8-K (May 20, 2026), 8-K (May 7, 2026), 10-Q (April 30, 2026).

What does LLY's latest filing analysis show?

LLY's most recent 8-K (August 5, 2026) is rated BULLISH, concern level MODERATE.

Is LLY a buy?

StockHuntr doesn't issue buy or sell ratings — it's a research tool. For ELI LILLY & Co (LLY), its latest 8-K is rated MODERATE concern. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.

Recent LLY filings analyzed

  • 8-K · Aug 5, 2026 · concern 2.1/10
  • 10-Q · Aug 5, 2026 · concern 6.2/10

Compare across the sector: Health Care sector analysis →

Other Health Care companies

JNJ · JOHNSON & JOHNSONABBV · AbbVie Inc.UNH · UNITEDHEALTH GROUP INCMRK · Merck & Co., Inc.TMO · THERMO FISHER SCIENTIFIC INC.AMGN · AMGEN INCGILD · GILEAD SCIENCES, INC.ABT · ABBOTT LABORATORIES

About this analysis

Primary source:
View this company's filings on SEC EDGAR
Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
August 5, 2026
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

Loading LLY snapshot...

Fetching live market data